🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research is being done to study the effects of the drug omalizumab (Xo...
Status
Completed
Location
Johns Hopkins Asthma and Allergy Center
Start Date
2007-07
Trial ID
NCT00604786
Treatments Being Tested
Elevated levels of immunoglobuline E in blood are said to promote the occur...
Status
Completed
Location
Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University of Vienna, Austria.
Start Date
2001-10
Trial ID
NCT00822783
Treatments Being Tested
Food allergies account for only a small percentage of all adverse reactions...
Status
Completed
Location
Multiple Locations
Start Date
2016-08-01
Trial ID
NCT05442658
Treatments Being Tested
A substance called immunoglobulin E (IgE), which is naturally produced by o...
Status
Completed
Location
Alabama Allergy and Asthma Center
Start Date
2004-04
Trial ID
NCT00079937
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of omaliz...
Status
Completed
Location
Jonathan Corren MD, Inc.
Start Date
2017-11-15
Trial ID
NCT03280550
Treatments Being Tested
In this project, the investigators would like to learn if 24 weeks (about 5...
Status
Recruiting
Location
Johns Hopkins
Start Date
2025-05-19
Trial ID
NCT06934200
Treatments Being Tested
The purpose of this study was to demonstrate the efficacy and safety of oma...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-12-15
Trial ID
NCT03369704
Treatments Being Tested
Assess efficacy and safety of omalizumab treatment during 12 months in orde...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-11-11
Trial ID
NCT01912872
Treatments Being Tested
Omalizumab will be given as add-on treatment to optimized asthma therapy in...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00264849
Treatments Being Tested
This study will evaluate the efficacy of QGE031 compared to omalizumab in p...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-11
Trial ID
NCT01703312
Treatments Being Tested